Cargando…
M2 macrophage-mediated interleukin-4 signalling induces myofibroblast phenotype during the progression of benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) is a progressive disease in elderly men, but potential factors accelerating its progression remain largely unknown. The aim of this study was to elucidate the factors affecting BPH progression by understanding the complex mechanisms causing early- progressed BPH, w...
Autores principales: | Sheng, Jindong, Yang, Yang, Cui, Yun, He, Shiming, Wang, Lu, Liu, Libo, He, Qun, Lv, Tianjing, Han, Wenke, Yu, Wei, Hu, Shuai, Jin, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037751/ https://www.ncbi.nlm.nih.gov/pubmed/29988032 http://dx.doi.org/10.1038/s41419-018-0744-1 |
Ejemplares similares
-
CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway
por: Yang, Yang, et al.
Publicado: (2017) -
Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis
por: Yang, Yang, et al.
Publicado: (2022) -
Activation of cGMP/PKG/p65 signaling associated with PDE5‐Is downregulates CCL5 secretion by CD8
(+) T cells in benign prostatic hyperplasia
por: Jin, Song, et al.
Publicado: (2019) -
Benign Prostatic Hyperplasia
Publicado: (2015) -
Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia
por: Xu, Deqiang, et al.
Publicado: (2019)